Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1881 (LINC01881) is a member of the long intergenic non-coding RNA (lincRNA) family, which comprises autonomously transcribed RNA genes longer than 200 nucleotides that do not overlap annotated protein-coding genes[1][3]. As a lincRNA, LINC01881 does not encode a protein but may be involved in the fine-tuning of neighboring gene expression through tissue-specific mechanisms, including chromatin architecture remodeling, transcriptional regulation, and potentially functioning as an enhancer RNA[3]. The functions of many lincRNAs remain poorly characterized, and there is currently limited published functional or disease-related information specifically about LINC01881; thus, it is not currently considered a well-established therapeutic target, receptor, or enzyme[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1881 (LINC01881).